Tags

Type your tag names separated by a space and hit enter

Developing a SARS-CoV-2 Vaccine at Warp Speed.
JAMA. 2020 Aug 04; 324(5):437-438.JAMA

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

O'Callaghan KP
Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Blatz AM
Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Offit PA
Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

MeSH

AdenoviridaeBetacoronavirusCoronavirus InfectionsDrug DevelopmentGenetic VectorsHumansPandemicsPneumonia, ViralRNA, ViralTime FactorsViral Vaccines

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32628244

Citation

O'Callaghan, Kevin P., et al. "Developing a SARS-CoV-2 Vaccine at Warp Speed." JAMA, vol. 324, no. 5, 2020, pp. 437-438.
O'Callaghan KP, Blatz AM, Offit PA. Developing a SARS-CoV-2 Vaccine at Warp Speed. JAMA. 2020;324(5):437-438.
O'Callaghan, K. P., Blatz, A. M., & Offit, P. A. (2020). Developing a SARS-CoV-2 Vaccine at Warp Speed. JAMA, 324(5), 437-438. https://doi.org/10.1001/jama.2020.12190
O'Callaghan KP, Blatz AM, Offit PA. Developing a SARS-CoV-2 Vaccine at Warp Speed. JAMA. 2020 Aug 4;324(5):437-438. PubMed PMID: 32628244.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Developing a SARS-CoV-2 Vaccine at Warp Speed. AU - O'Callaghan,Kevin P, AU - Blatz,Allison M, AU - Offit,Paul A, PY - 2020/7/7/pubmed PY - 2020/9/30/medline PY - 2020/7/7/entrez SP - 437 EP - 438 JF - JAMA JO - JAMA VL - 324 IS - 5 SN - 1538-3598 UR - https://www.unboundmedicine.com/medline/citation/32628244/full_citation L2 - https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12190 DB - PRIME DP - Unbound Medicine ER -